MiNK Therapeutics INKT
NASDAQ INKT
$12.55 +0.29 (+2.37%)
At close: Sep 30, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Capital Expenditures (2021 - 2023)

Updated

MiNK Therapeutics (INKT) recorded Capital Expenditures of $73,561 in FY2023, down 70.6% from $250,046 in FY2022.

Analysis

MiNK Therapeutics (INKT) Capital Expenditures (2021 - 2023) Analysis & Trends

Starting with FY2020, MiNK Therapeutics' Capital Expenditures history includes 4 years.

  • Annual Capital Expenditures has a three-year compound annual growth rate of -8.2% (FY2020 to FY2023).
  • Per Business Quant data, INKT's Capital Expenditures was $250,046 in FY2022 (+0.4%), $248,983 in FY2021 (+161.5%) and $95,212 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 MiNK Therapeutics 63.96 Mn 63.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 23,043.00
Jun 30, 2023 37,018.00
Mar 31, 2023 13,500.00
Dec 31, 2022 127,838.00
Sep 30, 2022 59,795.00
Dec 31, 2021 -277.00
Sep 30, 2021 111,820.00
Jun 30, 2021 97,920.00
Mar 31, 2021 39,520.00
API Access

MiNK Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INKT&period=max&api_key=YOUR_API_KEY